17.
Kerr S, Bedston S, Bradley DT, Joy M, Lowthian E, et al. Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. Int J Epidemiol. 2023;52(1):22–31.
https://doi.org/10.1093/ije/dy....